28 - 29 August, 2012, Novotel Clarke Quay Hotel, Singapore
Download the Brochure
Click here for Download Centre
"This event is a good start and will achieve another future milestone for years to come!"
- Director, Ministry of Health, Malaysia
"Good discussion on challenges in clinical trials."
- Regulatory Specialist, HSA, Singapore
"First-hand information on sharing among the experts in the field."
- Senior Manager, National University Health System, Singapore
"Good mix of topics on clinical trials."
- Senior CRM, Allergan
"Valuable practical scientific issues to be used back in the office!"
- Senior Clinical Scientist, Protech Pharmaservices Corporation
"Great opportunity to meet industry experts in Asia!"
- Clinical Research Manager, Daiichi Sankyo Taiwan
"IQPC brings together the experts you can learn from!"
- Director Patient Safety, Vanthys Pharmaceutical Development
Become a Pharma IQ Member and receive our weekly newsletter!
Connect to a global Pharma IQ social network
Learn more about sponsor & exhibit opportunities
Mark Your Calendar
Tell a Colleague
Innovation in Early Phase Trials
Joanne Chio, Head of Clinical Trials at the Haematology - Oncology Research Group (HORG), National University Cancer Institute, Singapore (NCIS), speaks to Pharma IQ about innovation in early phase trials. Joanne also shares her insights on emerging trends in early phase clinical trials and strategies to reduce clinical trial timelines and prevent failures.
5 dreadful illnesses that have had successful clinical trials in 2012
If you can’t do big, great things, then do great things in a small way. And there are plenty of people who are doing just that, laying the foundations to cure millions who seem to be suffering from illnesses. Pharma IQ takes a look at five ailments which we may soon see eliminated because of brilliant people doing great things in a small way.
Early Clinical Studies in Asia - why Asia, and where are the challenges and opportunities
Dr. Zaiqi Wang, MD, PhD, Director of Clinical Research, Singapore MSD Translational Research Centre, discusses the landscape of clinical development in Asia. He also talked about the drivers to shift early clinical studies to Asia – internally and externally and the challenges and opportunities of performing early clinical studies in Asia
Successful translation from pre-clinical to clinical studies - employment of imaging in phase I to optimise dosage in PoC studiesDorrit Østergaard Nilausen, Specialist, Clinical Pharmacology Scientist, Clinical Pharmacology & Pharmacokinetics, International Clinical Research for Lundbeck, links pre-clinical occupancy to clinical occupancy. He also uses PET as a facilitator of drug development in clinical phases.
Running clinical trials outside of Europe and the US
Dr. Benjamin G. Co, Medical Director, for Otsuka Philippines explores the advantages of conducting an early phase study in Philippines. He also examines whether the results for early phase study in Philippines will be accepted by the European and US regulatory authorities and how to help ensure that they will be.
[ Register Now ]